Swamynathan, Sudha
Tiwari, Anil
Loughner, Chelsea L.
Gnalian, John
Alexander, Nicholas
Jhanji, Vishal
Swamynathan, Shivalingappa K. http://orcid.org/0000-0002-9158-1511
Article History
Received: 25 October 2018
Accepted: 29 March 2019
First Online: 11 April 2019
Competing Interests
: S. Swamynathan (Patent); S.K. Swamynathan, (Patent); Anil Tiwari, None. C.L. Loughner, None; John Gnalian, None; Nicholas Alexander, None; Vishal Jhanji, None. Patent Details are given below. Patent number and status: 9,731,014 Issued in Aug 2017 Patent Title: Use of SLURP1 as an Immunomodulatory Molecule in the Ocular Surface Applicant: University of Pittsburgh, Pittsburgh, PA-15213, USA. Inventors: Shivalingappa K. Swamynathan, Sudha Swamynathan (Authors of this manuscript) Other inventors named in the patent: Kristine Buela, and Robert Hendricks Specific aspect of manuscript covered in patent application: This manuscript shows that SLURP1 acts as an immunomodulatory molecule by inhibiting neutrophil-endothelial cell interaction.